Everest Medicines Limited (1952.HK) HKSE

62.10

+1.45(+2.39%)

Updated at September 08 04:08PM

Currency In HKD

Valuation

Market Cap14.59B
Enterprise Value14.28B
P/E Ratio-17.7
PEG Ratio-28.68
Price/Sales Ratio28.05
Price/Book Ratio4.53
Enterprise/Revenue27.61
Enterprise/EBITDA-27.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-1.47
Operating Margin-1.58

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.24

Income Statement

Revenue706.68M
Revenue/Share2.18
Gross Profit528.89M
EBITDA-670.04M
Net Income-1.04B
Diluted EPS-3.24

Balance Sheet

Total Cash1.6B
Total Cash/Share4.94
Total Debt575.61M
Total Debt/Equity0.14
Current Ratio2.54
Book Value Per Share12.56

Price History

52-Week Change165.38
52-Week High77.55
52-Week Low21.15
Moving Average 50 Days68.49
Moving Average 200 Days52.37

Statistics

Average Volume7.87M
Shares Outstanding348.77M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A